E. Selg

发表

Two different mechanisms for modulation of bronchoconstriction in guinea-pigs by cyclooxygenase metabolites.

S. Dahlén, E. Selg, M. Andersson, 2009, Prostaglandins & other lipid mediators.

An experimental study of mediators in allergic bronchoconstriction with focus on eicosanoids

E. Selg, 2008 .

Investigation of Lung Pharmacokinetic of the Novel PDE4 Inhibitor CHF6001 in Preclinical Models: Evaluation of the PreciseInhale Technology.

F. Acevedo, E. Selg, P. Puccini, 2017, Journal of aerosol medicine and pulmonary drug delivery.

Antagonism of thromboxane receptors by diclofenac and lumiracoxib

S. Dahlén, B. Dahlén, A. Sala, 2007, British journal of pharmacology.

Effects of selective and non-selective COX inhibitors on antigen-induced release of prostanoid mediators and bronchoconstriction in the isolated perfused and ventilated guinea pig lung.

S. Dahlén, M. Kumlin, E. Selg, 2008, Prostaglandins, leukotrienes, and essential fatty acids.

Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform

E. Selg, P. Gerde, Carl-Olof Sjöberg, 2020, Journal of aerosol medicine and pulmonary drug delivery.

In Vitro to ex Vivo/In Vivo Correlation (IVIVC) of dissolution kinetics from inhaled particulate solutes using air/blood barrier models: Relation between in vitro design, lung physiology and kinetic output of models

Maria Malmlöf, E. Selg, P. Gerde, 2021 .

Use of PBPK Modeling To Evaluate the Performance of DissolvIt, a Biorelevant Dissolution Assay for Orally Inhaled Drug Products

Maria Malmlöf, S. Arora, E. Selg, 2019, Molecular pharmaceutics.

Delivering horseradish peroxidase as a respirable powder to the isolated, perfused, and ventilated lung of the rat: the pulmonary disposition of an inhaled model biopharmaceutical.

F. Acevedo, E. Selg, A. Ryrfeldt, 2010, Journal of aerosol medicine and pulmonary drug delivery.

Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution‐ and absorption rates in the lungs

Maria Malmlöf, E. Selg, H. Mascher, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate.

F. Acevedo, E. Selg, A. Ryrfeldt, 2013, Journal of aerosol medicine and pulmonary drug delivery.

Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles.

E. Selg, C. Foged, H. Franzyk, 2022, International journal of pharmaceutics.

Delivering horseradish peroxidase as a respirable powder to the isolated, perfused, and ventilated lung of the rat: the pulmonary disposition of an inhaled model biopharmaceutical.

F. Acevedo, E. Selg, A. Ryrfeldt, 2010, Journal of Aerosol Medicine.

Dry powder inhalation exposures of the endotracheally intubated rat lung, ex vivo and in vivo: the pulmonary pharmacokinetics of fluticasone furoate.

F. Acevedo, E. Selg, A. Ryrfeldt, 2013, Journal of aerosol medicine and pulmonary drug delivery.